| Cash Flow | 2025-08-31 |
|---|---|
| Net earnings (loss) | 92,749 |
| Net (loss) earnings from discontinued operations | 0 |
| Net earnings (loss) from continuing operations | 92,749 |
| Impairment and divestiture charges, net of tax effect | 0 |
| Depreciation and amortization | 15,674 |
| Stock-based compensation expense | 13,016 |
| (benefit) provision for deferred income taxes | -186 |
| Amortization of debt discount and debt issuance costs | 586 |
| Increase (decrease) in receivable reserve | 949 |
| Other non-cash adjustments | -1,111 |
| Accounts receivable | -3,432 |
| Inventories | 3,207 |
| Trade accounts payable | -4,222 |
| Prepaid expenses and other assets | 15,583 |
| Income taxes payable | 1,730 |
| Accrued compensation and benefits | 1,539 |
| Other accrued liabilities | 3,696 |
| Cash provided by operating activities, continuing operations | 111,284 |
| Cash provided by operating activities, discontinued operations | 0 |
| Cash provided by operating activities | 111,284 |
| Capital expenditures | 19,340 |
| Payments to acquire businesses, net of cash acquired | 26,661 |
| Proceeds from sale of property, plant and equipment | 0 |
| Working capital adjustment from sale of business assets | 0 |
| Purchase of assets | 0 |
| Proceeds from sale of businesses, net of transaction costs | 0 |
| Cash provided by (used in) investing activity, including discontinued operation | -46,001 |
| Borrowings on revolving credit | 14,421 |
| Principal repayment on revolving credit facility | -14,421 |
| Principal repayments on term loan | -5,000 |
| Proceeds from issuance of term loan | 0 |
| Payment for redemption of revolver | 0 |
| Repayments of lines of credit | 0 |
| Payments of debt issuance costs | 0 |
| Purchase of treasury shares | 68,742 |
| Stock options, taxes paid related to the net share settlement of equity awards & other | -5,548 |
| Cash dividend | 2,167 |
| Cash used in financing activities | -81,457 |
| Effect of exchange rate on cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | 638 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect, total | -15,536 |
| Cash and cash equivalents at beginning of period | 167,094 |
| Cash and cash equivalents at end of period | 151,558 |
ENERPAC TOOL GROUP CORP (EPAC)
ENERPAC TOOL GROUP CORP (EPAC)